Dr. Ravi Salgia
Claim this profileCity of Hope Medical Center
Area of expertise
Pancreatic Cancer
Ravi Salgia has run 2 trials for Pancreatic Cancer. Some of their research focus areas include:
Lung Cancer
Ravi Salgia has run 2 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
City Of Hope Medical Center
City Of Hope
Clinical Trials Ravi Salgia is currently running
Carfilzomib + Sotorasib
for Lung Cancer
This phase I trial tests the safety, side effects, and best dose of carfilzomib in combination with sotorasib in treating patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC) that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). Carfilzomib is a drug that binds to and inhibits the activity of the protein complex that is responsible for degrading other damaged or unneeded proteins. The inhibition of this protein by carfilzomib can then cause tumor growth inhibition and cell death. Sotorasib is a drug that binds to and inhibits the activity of the KRAS G12C mutant. This may inhibit growth in KRAS G12C-expressing tumor cells. Combining carfilzomib and sotorasib may be a safe and effective treatment option for patients with KRAS G12C-mutated advanced or metastatic NSCLC.
Recruiting
1 award
Phase 1
Combination Chemotherapy
for Pancreatic Cancer
This trial is testing a combination of three drugs for patients with pancreatic cancer that cannot be surgically removed. One drug blocks a hormone to stop cancer growth, while the other two drugs kill cancer cells or prevent them from multiplying. One of these drugs has been widely used in pancreatic cancer treatment, often in combination with other drugs to improve effectiveness.
Recruiting
1 award
Phase 1
16 criteria
More about Ravi Salgia
Clinical Trial Related
4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ravi Salgia has experience with
- Bosentan
- Gemcitabine
- Nab-paclitaxel
- Atezolizumab
- Carboplatin
- Etoposide
Breakdown of trials Ravi Salgia has run
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ravi Salgia specialize in?
Ravi Salgia focuses on Pancreatic Cancer and Lung Cancer. In particular, much of their work with Pancreatic Cancer has involved KRAS positive patients, or patients who are Stage IV.
Is Ravi Salgia currently recruiting for clinical trials?
Yes, Ravi Salgia is currently recruiting for 2 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Ravi Salgia has studied deeply?
Yes, Ravi Salgia has studied treatments such as Bosentan, Gemcitabine, Nab-paclitaxel.
What is the best way to schedule an appointment with Ravi Salgia?
Apply for one of the trials that Ravi Salgia is conducting.
What is the office address of Ravi Salgia?
The office of Ravi Salgia is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.